Esther Rajavelu

Board Member

CFO

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

SPRO

Current role

Board Member, CFO, CEO

2 calls Latest call 2025-08-12

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Spero Therapeutics, Inc. (SPRO)	President and Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer	$577,179	$687,479	$413,705	—	$372,000	$11,134	$2,061,496
2024	Spero Therapeutics, Inc. (SPRO)	President and Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer	$483,313	—	$188,190	—	$173,993	$10,984	$856,479
2023	Spero Therapeutics, Inc. (SPRO)	Interim President and Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer	$73,769	$50,000	$333,000	—	—	$1,285	$458,054

Earnings-call appearances and filed executive appointments or departures, newest first.